世界の腫瘍崩壊症候群市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Tumor Lysis Syndrome Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z5758
• 出版社/出版日：QYResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、92ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品、ヘルスケア

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査資料では、腫瘍崩壊症候群のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（アロプリノール、フェブキソスタット、ラスブリカーゼ、その他）、用途別市場規模（病院薬局、小売薬局、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。
・市場概要
・腫瘍崩壊症候群の市場動向
・企業の競争状況、市場シェア
・腫瘍崩壊症候群の種類別市場規模（アロプリノール、フェブキソスタット、ラスブリカーゼ、その他）
・腫瘍崩壊症候群の用途別市場規模（病院薬局、小売薬局、その他）
・腫瘍崩壊症候群の北米市場規模2016-2027（アメリカ、カナダ）
・腫瘍崩壊症候群のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等）
・腫瘍崩壊症候群のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・腫瘍崩壊症候群の中南米市場規模2016-2027（メキシコ、ブラジル）
・腫瘍崩壊症候群の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Harman Finochem、Ironwood Pharmaceuticals、Mylan、AstraZeneca、Takeda Pharmaceutical Company）
・結論

Tumor lysis syndrome is a group of metabolic abnormalities that can occur as a complication during the treatment of cancer, where large amounts of tumor cells are killed off (lysed) at the same time by the treatment, releasing their contents into the bloodstream.

Market Analysis and Insights: Global Tumor Lysis Syndrome Market
The global Tumor Lysis Syndrome market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Tumor Lysis Syndrome market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Tumor Lysis Syndrome market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Tumor Lysis Syndrome market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Tumor Lysis Syndrome market.

Global Tumor Lysis Syndrome Scope and Market Size
Tumor Lysis Syndrome market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tumor Lysis Syndrome market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Allopurinol
Febuxostat
Rasburicase
Others

Segment by Application
Hospital Pharmacies
Retail pharmacies
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Harman Finochem
Ironwood Pharmaceuticals
Mylan
AstraZeneca
Takeda Pharmaceutical Company

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Tumor Lysis Syndrome Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Allopurinol
1.2.3 Febuxostat
1.2.4 Rasburicase
1.2.5 Others
1.3 Market by Application
1.3.1 Global Tumor Lysis Syndrome Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacies
1.3.3 Retail pharmacies
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Tumor Lysis Syndrome Market Perspective (2016-2027)
2.2 Tumor Lysis Syndrome Growth Trends by Regions
2.2.1 Tumor Lysis Syndrome Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Tumor Lysis Syndrome Historic Market Share by Regions (2016-2021)
2.2.3 Tumor Lysis Syndrome Forecasted Market Size by Regions (2022-2027)
2.3 Tumor Lysis Syndrome Industry Dynamic
2.3.1 Tumor Lysis Syndrome Market Trends
2.3.2 Tumor Lysis Syndrome Market Drivers
2.3.3 Tumor Lysis Syndrome Market Challenges
2.3.4 Tumor Lysis Syndrome Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Tumor Lysis Syndrome Players by Revenue
3.1.1 Global Top Tumor Lysis Syndrome Players by Revenue (2016-2021)
3.1.2 Global Tumor Lysis Syndrome Revenue Market Share by Players (2016-2021)
3.2 Global Tumor Lysis Syndrome Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Tumor Lysis Syndrome Revenue
3.4 Global Tumor Lysis Syndrome Market Concentration Ratio
3.4.1 Global Tumor Lysis Syndrome Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Tumor Lysis Syndrome Revenue in 2020
3.5 Tumor Lysis Syndrome Key Players Head office and Area Served
3.6 Key Players Tumor Lysis Syndrome Product Solution and Service
3.7 Date of Enter into Tumor Lysis Syndrome Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Tumor Lysis Syndrome Breakdown Data by Type
4.1 Global Tumor Lysis Syndrome Historic Market Size by Type (2016-2021)
4.2 Global Tumor Lysis Syndrome Forecasted Market Size by Type (2022-2027)

5 Tumor Lysis Syndrome Breakdown Data by Application
5.1 Global Tumor Lysis Syndrome Historic Market Size by Application (2016-2021)
5.2 Global Tumor Lysis Syndrome Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Tumor Lysis Syndrome Market Size (2016-2027)
6.2 North America Tumor Lysis Syndrome Market Size by Type
6.2.1 North America Tumor Lysis Syndrome Market Size by Type (2016-2021)
6.2.2 North America Tumor Lysis Syndrome Market Size by Type (2022-2027)
6.2.3 North America Tumor Lysis Syndrome Market Size by Type (2016-2027)
6.3 North America Tumor Lysis Syndrome Market Size by Application
6.3.1 North America Tumor Lysis Syndrome Market Size by Application (2016-2021)
6.3.2 North America Tumor Lysis Syndrome Market Size by Application (2022-2027)
6.3.3 North America Tumor Lysis Syndrome Market Size by Application (2016-2027)
6.4 North America Tumor Lysis Syndrome Market Size by Country
6.4.1 North America Tumor Lysis Syndrome Market Size by Country (2016-2021)
6.4.2 North America Tumor Lysis Syndrome Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Tumor Lysis Syndrome Market Size (2016-2027)
7.2 Europe Tumor Lysis Syndrome Market Size by Type
7.2.1 Europe Tumor Lysis Syndrome Market Size by Type (2016-2021)
7.2.2 Europe Tumor Lysis Syndrome Market Size by Type (2022-2027)
7.2.3 Europe Tumor Lysis Syndrome Market Size by Type (2016-2027)
7.3 Europe Tumor Lysis Syndrome Market Size by Application
7.3.1 Europe Tumor Lysis Syndrome Market Size by Application (2016-2021)
7.3.2 Europe Tumor Lysis Syndrome Market Size by Application (2022-2027)
7.3.3 Europe Tumor Lysis Syndrome Market Size by Application (2016-2027)
7.4 Europe Tumor Lysis Syndrome Market Size by Country
7.4.1 Europe Tumor Lysis Syndrome Market Size by Country (2016-2021)
7.4.2 Europe Tumor Lysis Syndrome Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Tumor Lysis Syndrome Market Size (2016-2027)
8.2 Asia-Pacific Tumor Lysis Syndrome Market Size by Type
8.2.1 Asia-Pacific Tumor Lysis Syndrome Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Tumor Lysis Syndrome Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Tumor Lysis Syndrome Market Size by Type (2016-2027)
8.3 Asia-Pacific Tumor Lysis Syndrome Market Size by Application
8.3.1 Asia-Pacific Tumor Lysis Syndrome Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Tumor Lysis Syndrome Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Tumor Lysis Syndrome Market Size by Application (2016-2027)
8.4 Asia-Pacific Tumor Lysis Syndrome Market Size by Region
8.4.1 Asia-Pacific Tumor Lysis Syndrome Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Tumor Lysis Syndrome Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Tumor Lysis Syndrome Market Size (2016-2027)
9.2 Latin America Tumor Lysis Syndrome Market Size by Type
9.2.1 Latin America Tumor Lysis Syndrome Market Size by Type (2016-2021)
9.2.2 Latin America Tumor Lysis Syndrome Market Size by Type (2022-2027)
9.2.3 Latin America Tumor Lysis Syndrome Market Size by Type (2016-2027)
9.3 Latin America Tumor Lysis Syndrome Market Size by Application
9.3.1 Latin America Tumor Lysis Syndrome Market Size by Application (2016-2021)
9.3.2 Latin America Tumor Lysis Syndrome Market Size by Application (2022-2027)
9.3.3 Latin America Tumor Lysis Syndrome Market Size by Application (2016-2027)
9.4 Latin America Tumor Lysis Syndrome Market Size by Country
9.4.1 Latin America Tumor Lysis Syndrome Market Size by Country (2016-2021)
9.4.2 Latin America Tumor Lysis Syndrome Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Tumor Lysis Syndrome Market Size (2016-2027)
10.2 Middle East & Africa Tumor Lysis Syndrome Market Size by Type
10.2.1 Middle East & Africa Tumor Lysis Syndrome Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Tumor Lysis Syndrome Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Tumor Lysis Syndrome Market Size by Type (2016-2027)
10.3 Middle East & Africa Tumor Lysis Syndrome Market Size by Application
10.3.1 Middle East & Africa Tumor Lysis Syndrome Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Tumor Lysis Syndrome Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Tumor Lysis Syndrome Market Size by Application (2016-2027)
10.4 Middle East & Africa Tumor Lysis Syndrome Market Size by Country
10.4.1 Middle East & Africa Tumor Lysis Syndrome Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Tumor Lysis Syndrome Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Harman Finochem
11.1.1 Harman Finochem Company Details
11.1.2 Harman Finochem Business Overview
11.1.3 Harman Finochem Tumor Lysis Syndrome Introduction
11.1.4 Harman Finochem Revenue in Tumor Lysis Syndrome Business (2016-2021)
11.1.5 Harman Finochem Recent Development
11.2 Ironwood Pharmaceuticals
11.2.1 Ironwood Pharmaceuticals Company Details
11.2.2 Ironwood Pharmaceuticals Business Overview
11.2.3 Ironwood Pharmaceuticals Tumor Lysis Syndrome Introduction
11.2.4 Ironwood Pharmaceuticals Revenue in Tumor Lysis Syndrome Business (2016-2021)
11.2.5 Ironwood Pharmaceuticals Recent Development
11.3 Mylan
11.3.1 Mylan Company Details
11.3.2 Mylan Business Overview
11.3.3 Mylan Tumor Lysis Syndrome Introduction
11.3.4 Mylan Revenue in Tumor Lysis Syndrome Business (2016-2021)
11.3.5 Mylan Recent Development
11.4 AstraZeneca
11.4.1 AstraZeneca Company Details
11.4.2 AstraZeneca Business Overview
11.4.3 AstraZeneca Tumor Lysis Syndrome Introduction
11.4.4 AstraZeneca Revenue in Tumor Lysis Syndrome Business (2016-2021)
11.4.5 AstraZeneca Recent Development
11.5 Takeda Pharmaceutical Company
11.5.1 Takeda Pharmaceutical Company Company Details
11.5.2 Takeda Pharmaceutical Company Business Overview
11.5.3 Takeda Pharmaceutical Company Tumor Lysis Syndrome Introduction
11.5.4 Takeda Pharmaceutical Company Revenue in Tumor Lysis Syndrome Business (2016-2021)
11.5.5 Takeda Pharmaceutical Company Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Tumor Lysis Syndrome Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Allopurinol
Table 3. Key Players of Febuxostat
Table 4. Key Players of Rasburicase
Table 5. Key Players of Others
Table 6. Global Tumor Lysis Syndrome Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Tumor Lysis Syndrome Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Tumor Lysis Syndrome Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Tumor Lysis Syndrome Market Share by Regions (2016-2021)
Table 10. Global Tumor Lysis Syndrome Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Tumor Lysis Syndrome Market Share by Regions (2022-2027)
Table 12. Tumor Lysis Syndrome Market Trends
Table 13. Tumor Lysis Syndrome Market Drivers
Table 14. Tumor Lysis Syndrome Market Challenges
Table 15. Tumor Lysis Syndrome Market Restraints
Table 16. Global Tumor Lysis Syndrome Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Tumor Lysis Syndrome Market Share by Players (2016-2021)
Table 18. Global Top Tumor Lysis Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Lysis Syndrome as of 2020)
Table 19. Ranking of Global Top Tumor Lysis Syndrome Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Tumor Lysis Syndrome Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Tumor Lysis Syndrome Product Solution and Service
Table 23. Date of Enter into Tumor Lysis Syndrome Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Tumor Lysis Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Tumor Lysis Syndrome Revenue Market Share by Type (2016-2021)
Table 27. Global Tumor Lysis Syndrome Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Tumor Lysis Syndrome Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Tumor Lysis Syndrome Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Tumor Lysis Syndrome Revenue Market Share by Application (2016-2021)
Table 31. Global Tumor Lysis Syndrome Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Tumor Lysis Syndrome Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Tumor Lysis Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Tumor Lysis Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Tumor Lysis Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Tumor Lysis Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Tumor Lysis Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Tumor Lysis Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Tumor Lysis Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Tumor Lysis Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Tumor Lysis Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Tumor Lysis Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Tumor Lysis Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Tumor Lysis Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Tumor Lysis Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Tumor Lysis Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Tumor Lysis Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Tumor Lysis Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Tumor Lysis Syndrome Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Tumor Lysis Syndrome Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Tumor Lysis Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Tumor Lysis Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Tumor Lysis Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Tumor Lysis Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Tumor Lysis Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Tumor Lysis Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Tumor Lysis Syndrome Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Tumor Lysis Syndrome Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Tumor Lysis Syndrome Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Tumor Lysis Syndrome Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Tumor Lysis Syndrome Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Tumor Lysis Syndrome Market Size by Country (2022-2027) & (US$ Million)
Table 63. Harman Finochem Company Details
Table 64. Harman Finochem Business Overview
Table 65. Harman Finochem Tumor Lysis Syndrome Product
Table 66. Harman Finochem Revenue in Tumor Lysis Syndrome Business (2016-2021) & (US$ Million)
Table 67. Harman Finochem Recent Development
Table 68. Ironwood Pharmaceuticals Company Details
Table 69. Ironwood Pharmaceuticals Business Overview
Table 70. Ironwood Pharmaceuticals Tumor Lysis Syndrome Product
Table 71. Ironwood Pharmaceuticals Revenue in Tumor Lysis Syndrome Business (2016-2021) & (US$ Million)
Table 72. Ironwood Pharmaceuticals Recent Development
Table 73. Mylan Company Details
Table 74. Mylan Business Overview
Table 75. Mylan Tumor Lysis Syndrome Product
Table 76. Mylan Revenue in Tumor Lysis Syndrome Business (2016-2021) & (US$ Million)
Table 77. Mylan Recent Development
Table 78. AstraZeneca Company Details
Table 79. AstraZeneca Business Overview
Table 80. AstraZeneca Tumor Lysis Syndrome Product
Table 81. AstraZeneca Revenue in Tumor Lysis Syndrome Business (2016-2021) & (US$ Million)
Table 82. AstraZeneca Recent Development
Table 83. Takeda Pharmaceutical Company Company Details
Table 84. Takeda Pharmaceutical Company Business Overview
Table 85. Takeda Pharmaceutical Company Tumor Lysis Syndrome Product
Table 86. Takeda Pharmaceutical Company Revenue in Tumor Lysis Syndrome Business (2016-2021) & (US$ Million)
Table 87. Takeda Pharmaceutical Company Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tumor Lysis Syndrome Market Share by Type: 2020 VS 2027
Figure 2. Allopurinol Features
Figure 3. Febuxostat Features
Figure 4. Rasburicase Features
Figure 5. Others Features
Figure 6. Global Tumor Lysis Syndrome Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacies Case Studies
Figure 8. Retail pharmacies Case Studies
Figure 9. Others Case Studies
Figure 10. Tumor Lysis Syndrome Report Years Considered
Figure 11. Global Tumor Lysis Syndrome Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Tumor Lysis Syndrome Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Tumor Lysis Syndrome Market Share by Regions: 2020 VS 2027
Figure 14. Global Tumor Lysis Syndrome Market Share by Regions (2022-2027)
Figure 15. Global Tumor Lysis Syndrome Market Share by Players in 2020
Figure 16. Global Top Tumor Lysis Syndrome Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Lysis Syndrome as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Tumor Lysis Syndrome Revenue in 2020
Figure 18. Global Tumor Lysis Syndrome Revenue Market Share by Type (2016-2021)
Figure 19. Global Tumor Lysis Syndrome Revenue Market Share by Type (2022-2027)
Figure 20. North America Tumor Lysis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Tumor Lysis Syndrome Market Share by Type (2016-2027)
Figure 22. North America Tumor Lysis Syndrome Market Share by Application (2016-2027)
Figure 23. North America Tumor Lysis Syndrome Market Share by Country (2016-2027)
Figure 24. United States Tumor Lysis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Tumor Lysis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Tumor Lysis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Tumor Lysis Syndrome Market Share by Type (2016-2027)
Figure 28. Europe Tumor Lysis Syndrome Market Share by Application (2016-2027)
Figure 29. Europe Tumor Lysis Syndrome Market Share by Country (2016-2027)
Figure 30. Germany Tumor Lysis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Tumor Lysis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Tumor Lysis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Tumor Lysis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Tumor Lysis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Tumor Lysis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Tumor Lysis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Tumor Lysis Syndrome Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Tumor Lysis Syndrome Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Tumor Lysis Syndrome Market Share by Region (2016-2027)
Figure 40. China Tumor Lysis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Tumor Lysis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Tumor Lysis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Tumor Lysis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Tumor Lysis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Tumor Lysis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Tumor Lysis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Tumor Lysis Syndrome Market Share by Type (2016-2027)
Figure 48. Latin America Tumor Lysis Syndrome Market Share by Application (2016-2027)
Figure 49. Latin America Tumor Lysis Syndrome Market Share by Country (2016-2027)
Figure 50. Mexico Tumor Lysis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Tumor Lysis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Tumor Lysis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Tumor Lysis Syndrome Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Tumor Lysis Syndrome Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Tumor Lysis Syndrome Market Share by Country (2016-2027)
Figure 56. Turkey Tumor Lysis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Tumor Lysis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Tumor Lysis Syndrome Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Harman Finochem Revenue Growth Rate in Tumor Lysis Syndrome Business (2016-2021)
Figure 60. Ironwood Pharmaceuticals Revenue Growth Rate in Tumor Lysis Syndrome Business (2016-2021)
Figure 61. Mylan Revenue Growth Rate in Tumor Lysis Syndrome Business (2016-2021)
Figure 62. AstraZeneca Revenue Growth Rate in Tumor Lysis Syndrome Business (2016-2021)
Figure 63. Takeda Pharmaceutical Company Revenue Growth Rate in Tumor Lysis Syndrome Business (2016-2021)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

以下、関連資料のご紹介

世界の細胞溶解市場規模・現状・予測（2021年-2027年）

Global Cell Lysis Market Size, Status and Forecast 2021-2027
QYR2104Z1198 2021年4月 92Pages
QYResearch社発行の本調査資料では、細胞溶解のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（消耗品、機器）、用途別市場規模（研究所、バイオ医薬品・バイオテクノロジー企業）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中...

世界の細胞溶解市場規模・現状・予測（2021年-2027年）

世界の腫瘍治療フィールド市場規模・現状・予測（2021年-2027年）

Global Tumor Treating Fields (TTFields) Market Size, Status and Forecast 2021-2027
QYR2104Z5761 2021年4月 94Pages
QYResearch社発行の本調査資料では、腫瘍治療フィールドのグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（低周波、中周波）、用途別市場規模（病院、診療所、がん・放射線治療センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、ア...

世界の交流電場腫瘍治療市場規模・現状・予測（2021年-2027年）

Global Alternating Electric Field Tumor Treatment Market Size, Status and Forecast 2021-2027
QYR2104Z0261 2021年4月 96Pages
QYResearch社発行の本調査資料では、交流電場腫瘍治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（低周波、中周波）、用途別市場規模（病院、クリニック、がん・放射線治療センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、...

世界のゾリンジャー-エリソン症候群検査市場規模・現状・予測（2021年-2027年）

Global Zollinger - Ellison Syndrome Testing Market Size, Status and Forecast 2021-2027
QYR2104Z6110 2021年4月 92Pages
QYResearch社発行の本調査資料では、ゾリンジャー-エリソン症候群検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（合成豚セクレチン、合成人間セクレチン）、用途別市場規模（病院、クリニック）、主要地域別市場規模（北米、アメリカ、ヨーロッ...

世界の周期的発熱症候群市場規模・現状・予測（2021年-2027年）

Global Periodic Fever Syndrome Market Size, Status and Forecast 2021-2027
QYR2104Z4515 2021年4月 99Pages
QYResearch社発行の本調査資料では、周期的発熱症候群のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（高IgD症候群、家族性地中海熱症候群、TNF受容体関連周期症候群、クリオピリン関連周期症候群、その他）、用途別市場規模（病院、ドラッグス...

世界の消化管間質腫瘍市場規模・現状・予測（2021年-2027年）

Global Gastrointestinal Stromal Tumor Market Size, Status and Forecast 2021-2027
QYR2104Z2500 2021年4月 99Pages
QYResearch社発行の本調査資料では、消化管間質腫瘍のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（胃、小腸、その他）、用途別市場規模（病院、クリニック、専門がん治療センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジ...

世界の脆弱X症候群遺伝子検査市場規模・現状・予測（2021年-2027年）

Global Fragile X Syndrome Genetic Testing Market Size, Status and Forecast 2021-2027
QYR2104Z2456 2021年4月 97Pages
QYResearch社発行の本調査資料では、脆弱X症候群遺伝子検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（遺伝子スクリーニング、生殖遺伝子検査、診断検査、遺伝子保因者検査、症状前検査）、用途別市場規模（病院、クリニック、診断センター）、...

世界のチャーグストラウス症候群市場規模・現状・予測（2021年-2027年）

Global Churg Strauss Syndrome Market Size, Status and Forecast 2021-2027
QYR2104Z1332 2021年4月 99Pages
QYResearch社発行の本調査資料では、チャーグストラウス症候群のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（生物製剤、免疫グロブリン、ワクチン、ステロイド、その他）、用途別市場規模（研究所、病院、クリニック、その他）、主要地域別市場規模...

世界の固形腫瘍検査市場規模・現状・予測（2021年-2027年）

Global Solid Tumor Testing Market Size, Status and Forecast 2021-2027
QYR2104Z5374 2021年4月 90Pages
QYResearch社発行の本調査資料では、固形腫瘍検査のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（従来検査、非従来検査）、用途別市場規模（病院、診断研究所、学術研究所）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、...

世界の細胞溶解市場規模・現状・予測（2021年-2027年） Cell lysis is vital step for study or research in proteomics, as protein can only be extracted if the cell lysis process is conducted. Furthermore, cell lysis is crucial step required to perform for nuclear extraction, after which the DNA is modified using the recombinant DNA technology. The growin…
世界の細胞溶解市場規模・現状・予測（2021年-2027年） Cell lysis is vital step for study or research in proteomics, as protein can only be extracted if the cell lysis process is conducted. Furthermore, cell lysis is crucial step required to perform for nuclear extraction, after which the DNA is modified using the recombinant DNA technology. The growin…
世界のバーター症候群治療薬市場規模・現状・予測（2021年-2027年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. Market Analysis and Insights: Global Bartter Syndrome Drugs Market The global Bartter Syndrome Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% du…
世界のバーター症候群治療市場規模・現状・予測（2021年-2027年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. The global market for Bartter syndrome treatment is expected to witness a moderate growth rate over the forecast period. Market Analysis and Insights: Global Bartter Syndrome Treatment Market The global Bart…
世界のクッシング症候群治療市場規模・現状・予測（2021年-2027年） Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most Cushing's syndrome cases are caused by pituitary adenoma, and multiple endocrine neoplasia. In terms of…